Axcelead Drug Discovery Partners, Inc.
Axcelead Drug Discovery Partners is a Takeda Pharmaceuticals spin-out providing integrated drug discovery solutions and specialized technical services across multiple therapeutic areas.
Novalix
Novalix is a premier contract research organization, dedicated to improving the critical early stages of drug discovery, combining exceptional scientific talent and exclusive technology with a comprehensive portfolio of world-class chemistry, biophysics and pharmacology capabilities.
SandboxAQ
Discover SandboxAQ, a B2B company using AI and quantum techniques to power Large Quantitative Models (LQMs) for advances in life sciences, navigation, and more.
Evotec
Evotec is a global leader in drug discovery and development, offering extensive CRO and CDMO services across all stages of the R&D continuum, from target identification to the clinic, delivering efficient, high-quality, and cost-effective solutions. We integrate deep disease understanding, a multimodality approach, advanced technologies and tailored solutions to enhance the probability of success. Our innovative and flexible approach supports collaboration through standalone CRO/CDMO services, integrated drug discovery and development programs, or strategic partnerships, regardless of your stage in the discovery-development journey.
HLA Protein Technologies Inc.
HLA Protein Technologies develops and manufactures validated soluble HLA Class I & II molecules and related services — quantitative peptide binding, epitope mapping, immune-target validation, and transplant antibody assay development for the development of immunotherapeutics and vaccines.
Ricoh Biosciences
Ricoh Biosciences, formerly Elixirgen Scientific, is a biotechnology company using proprietary human iPSC differentiation technology to accelerate drug discovery, disease modeling, and cell therapy development. It provides high-quality, scalable cellular platforms and assays to support research and therapeutic innovation.
Fog City Bio
Fog City Bio is a micro-CRO specializing in rapid ELISA and immunoassay optimization. We help biotech teams accelerate R&D by improving assay sensitivity, reproducibility, and speed.
BPS Bioscience Inc.
BPS Bioscience provides 4000+ recombinant proteins, cell lines, lentiviruses, and assay services, specializing in immunotherapy, epigenetics, CRISPR, and more to accelerate drug discovery.
FUJIFILM Corporation
Discover Fujifilm’s drug discovery services, including iPSC models, mRNA display, and medicinal chemistry, advancing health from prevention to treatment.
Biointron
Founded in 2012 and certified to ISO 9001:2015, Biointron is a CRO specializing in antibody discovery, expression, and optimization services for biotech and pharmaceutical companies.
Champions Oncology
Champions Oncology is a global preclinical and clinical research services provider that offers end-to-end oncology R&D solutions to biopharma organizations.
Standard BioTools
Standard BioTools provides an established portfolio of essential, standardized technologies that empower customers to scale and accelerate their life sciences research.
AxiomBio, Inc.
Axiom provides accurate, affordable predictive models that integrate cell-based toxicity data with clinical outcomes for precise ML/AI-driven risk assessments.
Pharmaron, Inc
Pharmaron is a premier life science service provider offering comprehensive research, development, and manufacturing service capabilities throughout the drug discovery, preclinical, clinical development, and commercialization process for small molecules, biologics, and CGT products.
Concept Life Sciences
Concept Life Sciences is a UK-based drug discovery CRO, helping global pharma and biotech companies accelerate their drug candidate to clinic by offering integrated drug discovery programs.
PhenoVista Biosciences
PhenoVista is a leader in the development and implementation of multiplexed, high-content, imaging-based, phenotypic assays for biopharmaceutical clients.
Endpoint Preclinical
Endpoint Preclinical is a provider of research consulting services for CROs, Pharmaceutical, Biotech, Medical Device, and Academic Labs.
Lonza Group AG
Lonza Bioscience Solutions provides life science researchers with the tools they need to develop and test critical drugs and therapies, from basic research to final product release.
Volition
Volition is a leading epigenetics biomarker company, renowned for its proprietary liquid biopsy immunoassay approach to profiling nucleosomes.
Biomodels, LLC
Biomodels, is an AAALAC accredited preclinical CRO that develops and executes predictive and highly translational efficacy studies for biotech and pharma companies in a variety of indications.
OracleBio
OracleBio is a global leader in quantitative digital pathology, providing image analysis services to Pharma and Biotech clients worldwide.
PicoImmune Co.
NanoBiotec (d/b/a PicoImmune) provides ultra-sensitive, multiplex and reliable bioassays to monitor protein and gene changes in miniscule samples from cell culture and patients to accelerate the discovery and development of novel therapeutics.
Alpha Lifetech Inc.
Alpha Lifetech Inc. is a premier supplier of antibodies, proteins, ELISA kits, and related biological reagents, there are over 20,000+ products in stock with various specifications to meet customer needs. The company was founded by a group of scientists with extensive experience in protein expression, antibody development, library construction.
acCELLerate GmbH
Based on 16 years of experience acCELLerate has developed freezing protocols and established well-controlled processes to prepare assay ready Frozen Instant Cells of high quality and robustness. acCELLerate provides assay ready cells from multiple cell lines, validated instaCELL bioassay kits, as well as custom cell banks of Frozen Instant Cells with comprehensive documentation to meet specific requirements of the different fields of application.
Cytokinetics
Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for people with debilitating diseases in which muscle performance is compromised and/or declining.
